Baboon syndrome (SDRIFE) after valsartan/hydrochlorothiazide intake for several years
Accepted: 29 November 2021
HTML: 730
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Herein, we present a case of baboon syndrome/SDRIFE that occurred after intake of valsartan/hydrochlorothiazide for several years. The patient falls within the five diagnostic criteria and to the best of our knowledge, there have been no previous reports associating valsartan/hydrochlorothiazide with baboon syndrome/SDRIFE. Withdrawal of the anti-hypertensive drugs and initiation of topical and systemic steroids provided symptomatic relief and follow-up showed favourable results with complete remission of the cutaneous eruptions.
Andersen K, Hjorth N, Menne T. The Baboon syndrome: Systemically induced allergic contact dermatitis. Contact Dermatitis 1984;10:97-100.
Häusermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: Is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis 2004;51:297-310.
Mofarrah R, Mofarrah R, Kränke B, et al. First report of tamoxifen-induced baboon syndrome. J Cosmet Dermatol 2021;20:2574-8.
Roopa B, Kumar SK, Rohini MP, Prasanna V. Case report-baboon syndrome with paracetamol. Int J Basic Clin Pharmacol 2018;7:1-4
Elmariah SB, Cheung W, Wang N, et al. Systemic drug-related intertriginous and flexural exanthema (SDRIFE). Dermatol Online J 2009;15:3.
Copyright (c) 2022 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.